Status:
COMPLETED
Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass
Lead Sponsor:
IRCCS Policlinico S. Donato
Conditions:
Cardiac Complications
Cardiopulmonary Bypass
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Cardiopulmonary bypass (CPB) for cardiac operations may be accompanied by different patterns of visceral underperfusion. This could result in clinical patterns of lactic acidosis but in the most sever...
Detailed Description
Randomized placebo-controlled double blinded study. Patients undergoing complex cardiac operations will be randomly allocated to the study or the control group. All the patients will receive the stan...
Eligibility Criteria
Inclusion
- Complex, combined cardiac operation
- Predicted CPB duration \> 90 minutes
Exclusion
- Age \< 18 years
- No written informed consent
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00747331
Start Date
September 1 2008
End Date
April 1 2009
Last Update
April 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico S.Donato
San Donato Milanese, Milan, Italy, 20097